Dickinson, G. L., Lennard, M. S., Tucker, G. T., & Rostami-Hodjegan, A. (2007). The use of mechanistic DM-PK-PD modelling to assess the power of pharmacogenetic studies –CYP2C9 and warfarin as an example. Blackwell Science Inc.
Citação norma ChicagoDickinson, Gemma L., Martin S. Lennard, Geoffrey T. Tucker, and Amin Rostami-Hodjegan. The Use of Mechanistic DM-PK-PD Modelling to Assess the Power of Pharmacogenetic Studies –CYP2C9 and Warfarin As an Example. Blackwell Science Inc, 2007.
Citação norma MLADickinson, Gemma L., Martin S. Lennard, Geoffrey T. Tucker, and Amin Rostami-Hodjegan. The Use of Mechanistic DM-PK-PD Modelling to Assess the Power of Pharmacogenetic Studies –CYP2C9 and Warfarin As an Example. Blackwell Science Inc, 2007.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.